Filtros de búsqueda

Lista de obras de

61A User requirements for the meta-analysis of individual patient data

scholarly article

A "CONSORT'd" Effort to Improve the Reporting of Urological Randomized Controlled Trials

artículo científico publicado en 2016

A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards model

artículo científico publicado en 2005

A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma

scientific article published on 15 November 2006

A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma

artículo científico publicado en 2010

A single immediate instillation of chemotherapy for non-muscle invasive bladder cancer: in all patients?

artículo científico publicado en 2018

A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials

artículo científico publicado en 2004

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

artículo científico publicado en 2015

An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed?

artículo científico publicado en 2009

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer

artículo científico publicado en 2009

Assessing the quality of studies on the diagnostic accuracy of tumor markers ⬇️

artículo científico publicado en 2014

Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).

artículo científico publicado en 2005

Bacillus Calmette-Guérin versus mitomycin C for the treatment of intermediate-risk non-muscle-invasive bladder cancer: the debate continues

artículo científico publicado en 2009

Bacillus Calmette–Guérin treatment of non‐muscle invasive bladder cancer ⬇️

artículo científico publicado el 22 de noviembre de 2010

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials

artículo científico publicado en 2005

Blinking suppresses the neural response to unchanging retinal stimulation

artículo científico publicado en 2005

Can radical prostatectomy benefit patients despite the presence of regional metastases?

artículo científico publicado en 2010

Chemohyperthermia with Mitomycin-C Compared with Bacillus Calmette-Guérin: A "Hot" Topic

artículo científico publicado en 2016

Combined orientation and colour information in human V1 for both L-M and S-cone chromatic axes

artículo científico publicado en 2007

Combining a molecular profile with a clinical and pathological profile: biostatistical considerations

artículo científico publicado en 2008

Concepts for banking tissue in urologic oncology--the International Bladder Cancer Bank.

artículo científico publicado en 2005

Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree

artículo científico publicado en 2016

Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer

article

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

artículo científico publicado en 2004

Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group

artículo científico publicado en 2016

Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Non Muscle Invasive Bladder Cancer Follow up: A Blinded, Prospective Cohort, Multicentric European Study

scientific article published on 21 April 2020

Diagnostic accuracy of photodynamic diagnosis with 5-aminolevulinic acid, hexaminolevulinate and narrow band imaging for non-muscle invasive bladder cancer

scientific article published on 01 January 2020

Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis

scientific article published on 17 October 2019

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

scientific article published on 17 June 2016

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

artículo científico publicado en 2008

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update

artículo científico publicado en 2011

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.

artículo científico

EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ

artículo científico publicado en 2005

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.

artículo científico publicado en 2015

Editorial comment on: prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials

artículo científico publicado en 2007

Ensuring Consistent European-Wide Urological Care by the Use of Evidence-Based Clinical Practice Guidelines: Can We Do Better

scientific article published on 21 November 2017

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

artículo científico publicado en 2021

European Association of Urology Guidelines Office: How We Ensure Transparent Conflict of Interest Disclosure and Management

scientific article published on 25 January 2020

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

scientific article published on 20 August 2019

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.

artículo científico publicado en 2017

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

artículo científico publicado en 2020

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

artículo científico

European Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas: 2011 Update ⬇️

artículo científico publicado el 14 de enero de 2011

European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update ⬇️

artículo científico publicado el 19 de marzo de 2013

Exploratory Subgroup Analyses of Renal Function and Overall Survival in European Organization for Research and Treatment of Cancer randomized trial of Nephron-sparing Surgery Versus Radical Nephrectomy

artículo científico publicado en 2017

Extraretinal saccadic signals in human LGN and early retinotopic cortex

artículo científico publicado en 2005

Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin

artículo científico publicado en 2011

Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of mainte

artículo científico publicado en 2012

Frailty modelling for survival data from multi‐centre clinical trials ⬇️

artículo científico publicado el 12 de mayo de 2011

Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".

artículo científico publicado en 2018

Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trial

artículo científico publicado en 2006

High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder

artículo científico publicado en 2005

How Well Can You Actually Predict Which Non–Muscle-Invasive Bladder Cancer Patients Will Progress? ⬇️

artículo científico publicado el 12 de junio de 2011

Hyperfractionated or accelerated radiotherapy for head and neck cancer

artículo científico publicado en 2010

Hyperfractionated or accelerated radiotherapy for head and neck cancer.

scientific article published on 08 December 2010

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

artículo científico publicado en 2006

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

artículo científico publicado en 2014

Increasing age is not associated with toxicity leading to discontinuation of treatment in patients with urothelial non-muscle-invasive bladder cancer randomised to receive 3 years of maintenance bacille Calmette-Guérin: results from European Organis

artículo científico publicado en 2016

Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?

scientific article published on 27 July 2018

Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

artículo científico publicado en 2010

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial ⬇️

artículo científico publicado el 18 de abril de 2011

Interview with Dr Richard Sylvester: transition cell carcinoma of the bladder. Interview by Christine McKillop

artículo científico publicado en 2007

Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials

artículo científico publicado en 2002

Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?

scientific article published on 15 March 2007

Is overall survival not influenced by partial vs radical nephrectomy?

artículo científico publicado en 2018

Key Steps in Conducting Systematic Reviews for Underpinning Clinical Practice Guidelines: Methodology of the European Association of Urology

artículo científico publicado en 2017

Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease

artículo científico publicado en 2017

Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.

artículo científico publicado en 2004

Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and [...]

artículo científico publicado en 2009

Longitudinally extensive transverse myelitis: a rare association with common variable immunodeficiency

scientific article published on 21 October 2014

Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial ⬇️

artículo científico publicado el 1 de octubre de 2003

Maintenance Bacillus Calmette-Guérin Therapy: The Search for the Optimum Treatment Schedule Continues

artículo científico publicado en 2015

Maintenance bacillus Calmette-Guérin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence

artículo científico publicado en 2013

Managing recovery from concussion

artículo científico publicado en 2016

Moving concussion care to the next level: The emergence and role of concussion clinics in the UK.

artículo científico publicado en 2017

Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.

artículo científico publicado en 2002

NMIBC risk calculators: how useful are they for the practicing urologist and how can their clinical utility be improved?

artículo científico publicado en 2013

Natural history, recurrence, and progression in superficial bladder cancer.

artículo científico publicado en 2006

Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.

artículo científico publicado en 2016

Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review

artículo científico publicado en 2017

Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum

artículo científico publicado en 2005

P19 An integrated system for meta-analyses of individual patient data: Data dictionary and database structure

artículo científico publicado en 1995

P52 Can the forest plot be simplified without loosing relevant information in meta-analyses? ⬇️

scholarly article

Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?

artículo científico publicado en 2019

Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.

artículo científico publicado en 2017

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials

artículo científico publicado en 2006

Primum non nocere: a call for balance when reporting on CTE

artículo científico publicado en 2019

Professor Maurice Staquet, MD, MS (1930 - 2013).

artículo científico publicado en 2013

Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Pane

artículo científico publicado en 2017

Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature

artículo científico publicado en 2015

Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients

artículo científico publicado en 2014

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

artículo científico publicado en 2002

Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studi

artículo científico publicado en 2014

Progression-free survival rate as primary end point for phase II cancer clinical trials: application to mesothelioma--The EORTC Lung Cancer Group

artículo científico publicado en 2006

Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.

artículo científico publicado en 2008

Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.

artículo científico publicado en 2009

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986

artículo científico publicado en 2011

Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group

scientific article published on 01 June 2005

Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.

artículo científico publicado en 2012

Rapid-onset flaccid paraplegia caused by multiple myeloma dumbbell tumour

artículo científico publicado en 2014

Re: A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences: I. Berrum-svennung, T. Granfors, S. Jahnson, H. Boman and S. Holmang. J Urol 2008; 179: 101-106.

artículo científico publicado en 2008

Re: Can early single dose instillation of epirubicin improve bacillus calmette-guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study: T. Cai, G. Nesi, G. T

artículo científico publicado en 2008

Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparat

scientific article published on 16 June 2017

Re: Shahrokh F. Shariat, Behfar Ehdaie, Michael Rink, et al. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur urol 2012;61:237-42

artículo científico publicado el 24 de abril de 2012

Re: The Result of the Meta-analysis Depends on the Statistical Test Used: Clinical Implication is Important

artículo científico publicado en 2020

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy

artículo científico publicado en 2009

Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.

artículo científico

Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.

artículo científico publicado en 2018

Reply to Donald L. Lamm and Nilay M. Gandhi's letter to the editor re: Behfar Ehdaie, Richard Sylvester, Harry W. Herr. Maintenance bacillus Calmette-Guérin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence. Eur

artículo científico publicado en 2013

Reply to Donald Lamm, Andreas Böhle, Joan Palou, et al.’s Letter to the Editor re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing I

artículo científico publicado en 2010

Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61

artículo científico publicado en 2016

Reply to Mustafa Aldemir and Abdullah Erdem Canda’s Letter to the Editor re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intrave

artículo científico publicado en 2010

Reply to Per-Uno Malmström and Bruce J. Trock's Letter to the Editor re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Ins

artículo científico publicado en 2015

Reply to Philipp Dahm, Vikram Narayan, and Jae Hung Jung's Letter to the Editor re: Richard J. Sylvester, Steven E. Canfield, Thomas B.L. Lam, et al. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and M

artículo científico publicado en 2017

Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Su

artículo científico publicado en 2016

Reply to Stephen B. Williams, Donald L. Lamm, Ashish M. Kamat's Letter to the Editor re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Sing

artículo científico publicado en 2015

Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma

artículo científico publicado en 2012

Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel

artículo científico publicado en 2018

Saccades differentially modulate human LGN and V1 responses in the presence and absence of visual stimulation

artículo científico publicado en 2005

Sample size computation in phase II designs combining the A'Hern design and the Sargent and Goldberg design

artículo científico publicado en 2019

Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 t

artículo científico publicado en 2010

Should All Patients Receive an Immediate Chemotherapeutic Drug Instillation After Resection of Papillary Bladder Tumors? ⬇️

artículo científico publicado el 14 de diciembre de 2010

Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full d

artículo científico

Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials

artículo científico publicado en 2005

Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Car

artículo científico publicado en 2015

Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guérin

scientific article published on 03 March 2020

Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma

artículo científico

The Effect of Strength Training on the Jump-Landing Biomechanics of Young Female Athletes: Results of a Randomized Controlled Trial

artículo científico publicado en 2016

The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal product

artículo científico publicado en 2015

The International Bladder Cancer Bank: proposal for a new study concept

artículo científico publicado en 2004

The River: A Moral Tale

artículo científico publicado en 1994

The Role of Fluorescence In Situ Hybridization for Predicting Recurrence after Adjuvant bacillus Calmette-Guérin in Patients with Intermediate and High Risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patie

artículo científico publicado en 2019

The Side Effects of Bacillus Calmette-Guerin in the Treatment of Ta T1 Bladder Cancer Do Not Predict its Efficacy: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial ⬇️

artículo científico publicado el 1 de octubre de 2003

The Training and Accreditation of Psychotherapists and Counsellors

artículo científico publicado en 1992

The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.

artículo científico publicado en 2014

The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer.

artículo científico publicado en 2016

The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin

artículo científico publicado en 2015

The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer.

artículo científico publicado en 2009

The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials

artículo científico publicado en 2008

The use of intravesical chemotherapy and possibilities for improving its efficacy

artículo científico publicado en 2006

Therapeutic options in high-risk non-muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-Guérin

artículo científico publicado en 2014

Thoughts on a systematic review and meta-analysis of adjuvant chemotherapy in muscle-invasive bladder cancer

artículo científico publicado en 2014

Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer

scientific article published on 16 March 2020

Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.

artículo científico

Using the continual reassessment method: lessons learned from an EORTC phase I dose finding study

scientific article published on 05 June 2006

Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies

artículo científico publicado en 2002

Variable selection in subdistribution hazard frailty models with competing risks data

artículo científico publicado en 2014

Visual FMRI responses in human superior colliculus show a temporal-nasal asymmetry that is absent in lateral geniculate and visual cortex

artículo científico publicado en 2006

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

artículo científico publicado en 2002

What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel. ⬇️

artículo científico publicado en 2017

What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urolo

scientific article published on 08 October 2019

[EAU guidelines on non-muscle-carcinoma of the bladder]

scientific article published on 01 April 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda